Business Context and Reporting Period
Company: Hercules Technology Growth Capital, Inc. (HTGC)
Filing Type: Form 10-K (Annual Report)
Period Ended: December 31, 2007
Business Overview: HTGC is an internally managed, non-diversified, closed-end investment company regulated as a Business Development Company (BDC) and taxed as a Regulated Investment Company (RIC). The company provides debt and equity growth capital, primarily structured mezzanine debt, to technology-related and life-science companies at various stages of development (emerging-growth, expansion, and established). Investments are primarily in U.S.-based private companies backed by venture capital and private equity firms.
Key Financial Metrics
| Metric | 2007 | 2006 |
|---|---|---|
| Total Investment Income | $53.9 million | $29.5 million |
| Net Investment Income | $32.5 million | $10.5 million |
| Net Realized Gains (Losses) | $2.8 million | ($1.6 million) |
| Net Unrealized Appreciation | $7.3 million | $2.5 million |
| Net Increase in Net Assets from Operations | $42.4 million | $11.4 million |
| Total Assets | $541.9 million | $301.1 million |
| Total Investments (at Fair Value) | $530.0 million | $283.2 million |
| Total Liabilities | $141.2 million | $45.7 million |
| Total Net Assets | $400.7 million | $255.4 million |
| Net Asset Value (NAV) per Share | $12.31 | $11.65 |
| Dividends Declared per Share | $1.20 | $1.20 |
| Weighted Average Yield on Debt | 12.8% | N/A |
| Asset Coverage Ratio | 675% | N/A |
Material Changes vs. Prior Period
- Portfolio Growth: The investment portfolio grew by approximately 87% year-over-year, from $283.2 million to $530.0 million, driven by $355.5 million in funded debt investments and $12.6 million in equity investments.
- Revenue Expansion: Total investment income increased 83% to $53.9 million, primarily due to a larger portfolio and higher interest income ($48.8 million vs. $26.3 million).
- Profitability: Net investment income surged to $32.5 million from $10.5 million. Operating expenses increased to $21.4 million from $18.4 million, largely due to higher employee compensation ($9.1 million vs. $5.8 million) and stock-based compensation.
- Capital Structure: Total debt increased significantly. The company utilized a $250 million securitized credit facility (outstanding: $79.2 million) and SBA debentures (outstanding: $55.1 million), compared to $41.0 million in total debt in 2006.
- Realized Gains: The company reported net realized gains of $2.8 million in 2007, a reversal from a net realized loss of $1.6 million in 2006, attributed to the sale of equity securities in communications and biopharmaceutical companies.
Guidance, Outlook, Risks, and Unusual Items
- Outlook: Management anticipates continued growth through a combination of debt and equity capital. The company expects to fund investment activities through future equity offerings and borrowings, subject to 1940 Act asset coverage requirements.
- Market Conditions: The filing notes that the debt and equity capital markets were impacted by subprime mortgage write-offs and credit risk re-pricing, potentially increasing the cost of capital and reducing availability. However, HTGC believes it is well-positioned to access alternative debt markets.
- Key Risks:
- Concentration Risk: The portfolio is concentrated in technology and life sciences. The ten largest portfolio companies represented 33.7% of the total fair value of investments.
- Valuation Uncertainty: Approximately 98% of assets are investments in private companies valued at fair value by the Board of Directors, which may differ materially from values realized upon disposal.
- Liquidity: Investments are generally illiquid. The company may need to sell assets to meet distribution requirements or regulatory tests.
- Regulatory: As a BDC and RIC, the company is subject to strict asset coverage (200%) and distribution requirements (90% of taxable income).
- Unusual Items:
- Warrant Participation Agreement: Citigroup holds a 10% participation right in realized gains on warrants collateralized under the credit facility. This agreement reduced realized gains by approximately $400,000 in 2007 and reduced unrealized gains by approximately $609,000.
- Excise Tax: The company recorded a provision for excise tax of $139,000 on undistributed earnings intended for distribution in 2008.
Investor Verification Checklist
- Portfolio Valuation: Verify the methodology used by the Board of Directors to determine fair value for the 98% of assets held in private companies, given the lack of a ready market.
- Concentration Risk: Review the specific performance of the top three portfolio companies (Zayo Bandwidth, Tectura Corporation, and IKANO Communications), which individually represented over 5% of net assets.
- Debt Covenants: Confirm compliance with the 200% asset coverage ratio required by the 1940 Act and the specific covenants of the Citigroup credit facility and SBA debentures.
- Cash Flow vs. Taxable Income: Assess the company's ability to meet distribution requirements given the presence of non-cash income (e.g., PIK interest, OID accretion) that must be distributed to maintain RIC status.
- Warrant Participation Impact: Evaluate the long-term impact of the Citigroup warrant participation agreement on future realized gains and net asset value.